This is a Validated Antibody Database (VAD) review about mouse Icos, based on 98 published articles (read how Labome selects the articles), using Icos antibody in all methods. It is aimed to help Labome visitors find the most suited Icos antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Icos synonym: AILIM; CCLP; CRP-1; H4; Ly115

BioLegend
Syrian golden hamster monoclonal (15F9)
  • flow cytometry; mouse; loading ...; fig 3j
BioLegend Icos antibody (Biolegend, 15F9) was used in flow cytometry on mouse samples (fig 3j). Front Immunol (2022) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Icos antibody (BioLegend, 313508) was used in flow cytometry on mouse samples (fig 2a). Sci Adv (2022) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 200 ug/ml; loading ...; fig 2e
BioLegend Icos antibody (BioLegend, 313510) was used in flow cytometry on mouse samples at 200 ug/ml (fig 2e). Sci Rep (2021) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; 1:200; loading ...; fig 3i
BioLegend Icos antibody (BioLegend, 7E.17G9) was used in flow cytometry on mouse samples at 1:200 (fig 3i). Cancer Res (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; fig 1h
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (fig 1h). Front Immunol (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s4a). Proc Natl Acad Sci U S A (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:100; fig 1e
BioLegend Icos antibody (BioLegend, 313520) was used in flow cytometry on mouse samples at 1:100 (fig 1e). elife (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Icos antibody (Biolegend, 313520) was used in flow cytometry on mouse samples (fig 3c). Nat Commun (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:250; loading ...; fig 1c, 7a
BioLegend Icos antibody (BioLegend, 313525) was used in flow cytometry on mouse samples at 1:250 (fig 1c, 7a). Cancer Res (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; loading ...; fig 3d
BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (fig 3d). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...
BioLegend Icos antibody (BioLegend, 313538) was used in flow cytometry on mouse samples . Cell (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:100; loading ...; fig 1a, 7s1a
BioLegend Icos antibody (Biolegend, 313518) was used in flow cytometry on mouse samples at 1:100 (fig 1a, 7s1a). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 2s2c
BioLegend Icos antibody (Biolegend, 313524) was used in flow cytometry on human samples (fig 2s2c). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 6d). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig s12a
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on human samples (fig s12a). Nat Commun (2020) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; 1:200; loading ...; fig 3c
BioLegend Icos antibody (BioLegend, 117405) was used in flow cytometry on mouse samples at 1:200 (fig 3c). elife (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s1a). BMC Immunol (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Icos antibody (Biolegend, 313508) was used in flow cytometry on mouse samples (fig 1d). Cell Rep (2019) ncbi
hamsters monoclonal (C398.4A)
  • other; human; loading ...; fig 7s1b
BioLegend Icos antibody (BioLegend, C398.4A) was used in other on human samples (fig 7s1b). elife (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 1b
BioLegend Icos antibody (Biolegend, 313525) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 5a). Front Immunol (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s16b
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s16b). Science (2019) ncbi
hamsters monoclonal (C398.4A)
  • mass cytometry; human; loading ...; fig 2b
BioLegend Icos antibody (Biolegend, 313502) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s5l
BioLegend Icos antibody (Biolegend, 313510) was used in flow cytometry on mouse samples (fig s5l). Cell (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2019) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Icos antibody (BioLegend, 7E.17G9) was used in flow cytometry on mouse samples (fig 6a). Cell (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rat; loading ...; fig 15a
BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on rat samples (fig 15a). PLoS ONE (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Icos antibody (BioLegend, 313529) was used in flow cytometry on mouse samples (fig 1c). Cell (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rat; fig s3c
  • flow cytometry; mouse; fig s3c
  • flow cytometry; human; loading ...; fig s3c
BioLegend Icos antibody (BioLegend, 313540) was used in flow cytometry on rat samples (fig s3c), in flow cytometry on mouse samples (fig s3c) and in flow cytometry on human samples (fig s3c). Immunity (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:400; loading ...; fig 4d
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:400 (fig 4d). Nat Commun (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig s1a
BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; loading ...; fig 2c
BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (fig 2c). Nat Commun (2017) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 3f
In order to investigate the role of the E-Id protein axis in the innate and adaptive lymphoid development, BioLegend Icos antibody (BioLegend, 117405) was used in flow cytometry on mouse samples (fig 3f). Immunity (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s1h
In order to investigate the role of IL-4Ralpha-mediated macrophage activation promote in lung and liver wound repair, BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples (fig s1h). Science (2017) ncbi
Syrian golden hamster monoclonal (15F9)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Icos antibody (Biolegend, 15F9) was used in flow cytometry on mouse samples (fig 3a). Nat Med (2017) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; 1:300; loading ...; fig 6c
In order to test if oncolytic poxvirus treatment improves anti-PD-L1 immunotherapy, BioLegend Icos antibody (BioLegend, 117406) was used in flow cytometry on mouse samples at 1:300 (fig 6c). Nat Commun (2017) ncbi
hamsters monoclonal (C398.4A)
  • mass cytometry; human; fig s8
BioLegend Icos antibody (BioLegend, 313502) was used in mass cytometry on human samples (fig s8). Nature (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig s2a
BioLegend Icos antibody (BioLegend, C.398.4A) was used in flow cytometry on human samples (fig s2a). JCI Insight (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human
  • flow cytometry; mouse; loading ...; fig 2b
In order to assess whether human T-cell leukemia virus type 1 bZIP factor enhances the proliferation of expressing T cells after stimulation via the T-cell receptor, BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on human samples and in flow cytometry on mouse samples (fig 2b). PLoS Pathog (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 2a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...
In order to study the effect of IL-13 and IL-33 pathways in dysregulated type 2 inflammation., BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 6d
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (tbl s2). Nat Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend Icos antibody (BioLegend, 313520) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 1b
BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on human samples (fig 1b). Nat Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 3
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 4c
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 4c). Diabetes (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on human samples . J Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; African green monkey; fig 1
In order to study lymph node-resident simian immunodeficiency virus env-specific T follicular helper cells due to vaccine induction in Rhesus Macaques, BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on African green monkey samples (fig 1). J Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; fig s4
BioLegend Icos antibody (biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s4). Theranostics (2015) ncbi
hamsters monoclonal (C398.4A)
BioLegend Icos antibody (BioLegend, 313510) was used . Nat Commun (2015) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse
BioLegend Icos antibody (BioLegend, 313516) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig 4
BioLegend Icos antibody (Biolegend, 7E.17G9) was used in flow cytometry on mouse samples (fig 4). J Immunol (2015) ncbi
hamsters monoclonal (C398.4A)
  • blocking or activating experiments; mouse; 20 ug/ml; fig 7
BioLegend Icos antibody (Biolegend, C398.4A) was used in blocking or activating experiments on mouse samples at 20 ug/ml (fig 7). J Immunol (2015) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rat; fig 3
BioLegend Icos antibody (BioLegend, C398.4A) was used in flow cytometry on rat samples (fig 3). Eur J Immunol (2015) ncbi
hamsters monoclonal (C398.4A)
BioLegend Icos antibody (BioLegend, C398.4a) was used . J Immunol (2014) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rhesus macaque; loading ...; fig s1c
In order to explore germinal center-related hyperimmune responses and disease severity during viral infection, BioLegend Icos antibody (Biolegend, C398.4A) was used in flow cytometry on rhesus macaque samples (fig s1c). J Immunol (2014) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; 1:100
BioLegend Icos antibody (Biolegend, c398.4A) was used in flow cytometry on human samples at 1:100. J Clin Invest (2014) ncbi
Invitrogen
hamsters monoclonal (C398.4A)
  • flow cytometry; human; 1:50; loading ...
Invitrogen Icos antibody (ThermoFisher, 15-9949-82) was used in flow cytometry on human samples at 1:50. bioRxiv (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 6e
Invitrogen Icos antibody (eBioscience, clone C398.4A) was used in flow cytometry on mouse samples (fig 6e). elife (2020) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig s5a
Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples (fig s5a). Nature (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s6b
Invitrogen Icos antibody (eBiosciences, C398.4A) was used in flow cytometry on mouse samples (fig s6b). Nat Commun (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:500; loading ...; fig s12c
Invitrogen Icos antibody (Thermo Fisher Scientific, 17-9949-82) was used in flow cytometry on mouse samples at 1:500 (fig s12c). Nat Commun (2018) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Icos antibody (eBiosciences, C398.4A) was used in flow cytometry on mouse samples (fig 2a). Cancer Cell (2018) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples (fig 6a). J Immunol (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen Icos antibody (eBioscience, C398.4A) was used in flow cytometry on mouse samples (fig 4d). J Immunol (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Icos antibody (eBioscience, C398.4A) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 4d
In order to investigate the involvement of achaete-scute complex homologue 2 in the pathogenesis of Sjogren's syndrome-like disease in the NOD/ShiLtJ mouse, Invitrogen Icos antibody (eBioscience, C398.4A) was used in flow cytometry on mouse samples (fig 4d). Immunol Lett (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; fig 4a
In order to generate and characterize Treg-of-B cells, Invitrogen Icos antibody (eBioscience, C398.4 A) was used in flow cytometry on mouse samples (fig 4a). Sci Rep (2017) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig s2b
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Icos antibody (eBiosciences, 7E.17G9) was used in flow cytometry on mouse samples (fig s2b). J Clin Invest (2017) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 7
In order to examine natural killer T cell development in mice deficient for SLAM family receptors, Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples (fig 7). J Exp Med (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, Invitrogen Icos antibody (eBiosciences, C398.4A) was used in flow cytometry on mouse samples . Mucosal Immunol (2017) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig s3g
Invitrogen Icos antibody (eBiosciences, 12-9942-81) was used in flow cytometry on mouse samples (fig s3g). Nat Immunol (2016) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 2e
Invitrogen Icos antibody (eBiosciences, 7E.17G9) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 1d
In order to test if T regulatory cells from mice lacking both DEF-6 and SWAP-70 have an increased capacity to become effector T regulatory cells due to altered IRF-4 activity, Invitrogen Icos antibody (eBioscience, 7E.17G) was used in flow cytometry on mouse samples (fig 1d). Arthritis Rheumatol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen Icos antibody (eBiocience, C398.4A) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig 1
Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples (fig 1). J Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; fig 6
Invitrogen Icos antibody (eBiosciences, C398.4A) was used in flow cytometry on mouse samples (fig 6). Nat Immunol (2015) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, Invitrogen Icos antibody (eBiosciences, 7E.17G9) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
hamsters monoclonal (C398.4A)
  • blocking or activating experiments; mouse; loading ...; fig 2a
In order to explore the relationship between ICOS signaling and FOXO1 in T follicular helper cells, Invitrogen Icos antibody (eBioscience, C398.4A) was used in blocking or activating experiments on mouse samples (fig 2a). Immunity (2015) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig s2
Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; human; fig 3
Invitrogen Icos antibody (eBioscience, 7E17G9) was used in flow cytometry on human samples (fig 3). Cell Res (2015) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; fig 5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen Icos antibody (eBioscience, C398.4A) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse
Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; loading ...; fig 3a
In order to explore the interaction between IL-2 and IL-7 in CD4 T-cell memory generation, Invitrogen Icos antibody (ebioscience, 7E.17G9) was used in flow cytometry on mouse samples (fig 3a). Nat Commun (2014) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, Invitrogen Icos antibody (eBioscience, 7E.17G9) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse
In order to investigate the role of BTB-ZF factors in lymphoid effector programs, Invitrogen Icos antibody (e-Bioscience, C398.4A) was used in flow cytometry on mouse samples . Nature (2012) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; fig 1
In order to characterize and compare T helper 1 and 17 cells, Invitrogen Icos antibody (eBiosciences, C398.4A) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2007) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rhesus macaque; fig 7
In order to discuss the use of in vitro expanded polyclonal CD4+ T cells to treat SIV infection, Invitrogen Icos antibody (eBioscience, C398.4A) was used in flow cytometry on rhesus macaque samples (fig 7). J Med Primatol (2006) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse
In order to elucidate how Schistosoma mansoni suppresses T cell activation, Invitrogen Icos antibody (eBiosciences, C3948.4A) was used in flow cytometry on mouse samples . J Immunol (2004) ncbi
Miltenyi Biotec
human monoclonal (REA192)
  • flow cytometry; human; fig 3a
Miltenyi Biotec Icos antibody (Miltenyi Biotec, REA192) was used in flow cytometry on human samples (fig 3a). J Autoimmun (2018) ncbi
human monoclonal (REA192)
  • flow cytometry; human; loading ...; fig 7a
Miltenyi Biotec Icos antibody (Miltenyi Biotec, REA192) was used in flow cytometry on human samples (fig 7a). Sci Rep (2017) ncbi
Bio X Cell
rat monoclonal (7E.17G9)
  • blocking or activating experiments; human
Bio X Cell Icos antibody (BioXcell, 17G9) was used in blocking or activating experiments on human samples . Cell Res (2015) ncbi
BD Biosciences
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig s2
In order to suggest that lung group 2 innate lymphoid cells promote B cell production of early antibodies to a respiratory antigen even in the absence of T cells, BD Biosciences Icos antibody (BD Biosciences, 7E.17G9) was used in flow cytometry on mouse samples (fig s2). J Immunol (2016) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig 1, 2
In order to evaluate alleviation from psoriatic inflammation by programmed cell death ligand 1 and suppression of IL-17A production from programmed cell death 1-high T cells, BD Biosciences Icos antibody (BD Biosciences, 17G9) was used in flow cytometry on mouse samples (fig 1, 2). J Allergy Clin Immunol (2016) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; fig 3
BD Biosciences Icos antibody (BD Biosciences, 7E.17G9) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2015) ncbi
rat monoclonal (7E.17G9)
  • flow cytometry; mouse; 1:200; fig s7
BD Biosciences Icos antibody (BD, 552146) was used in flow cytometry on mouse samples at 1:200 (fig s7). Nat Commun (2015) ncbi
Articles Reviewed
  1. Erlandsson M, Erdogan S, Was xe9 n C, Andersson K, Silfversw xe4 rd S, Pullerits R, et al. IGF1R signalling is a guardian of self-tolerance restricting autoantibody production. Front Immunol. 2022;13:958206 pubmed publisher
  2. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  3. Patial S, Lewis B, Vo T, Choudhary I, Paudel K, Mao Y, et al. Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs. Sci Rep. 2021;11:15465 pubmed publisher
  4. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  5. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  6. Lin X, Twelkmeyer T, Zhu D, Zhang L, Zhao Y, Zhang C, et al. Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  7. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed publisher
  8. Yang Y, Li X, Ma Z, Wang C, Yang Q, Byrne Steele M, et al. CTLA-4 expression by B-1a B cells is essential for immune tolerance. Nat Commun. 2021;12:525 pubmed publisher
  9. Kharkwal S, Johndrow C, Veerapen N, Kharkwal H, Saavedra Avila N, Carreño L, et al. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy. Cancer Res. 2021;81:1788-1801 pubmed publisher
  10. Rundqvist H, Veliça P, Barbieri L, Gameiro P, Bargiela D, Gojkovic M, et al. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. elife. 2020;9: pubmed publisher
  11. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  12. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed publisher
  13. Gryzik S, Hoang Y, Lischke T, Mohr E, Venzke M, Kadner I, et al. Identification of a super-functional Tfh-like subpopulation in murine lupus by pattern perception. elife. 2020;9: pubmed publisher
  14. Vacca F, Chauch C, Jamwal A, Hinchy E, Heieis G, Webster H, et al. A helminth-derived suppressor of ST2 blocks allergic responses. elife. 2020;9: pubmed publisher
  15. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed publisher
  16. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  17. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  18. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  19. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  20. Mantani P, Dunér P, Ljungcrantz I, Nilsson J, Bjorkbacka H, Fredrikson G. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20:47 pubmed publisher
  21. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  22. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed publisher
  23. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  24. Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki I, et al. PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation. Front Immunol. 2019;10:630 pubmed publisher
  25. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  26. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  27. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  28. Qian L, Bajana S, Georgescu C, Peng V, Wang H, Adrianto I, et al. Suppression of ILC2 differentiation from committed T cell precursors by E protein transcription factors. J Exp Med. 2019;216:884-899 pubmed publisher
  29. Marcandalli J, Fiala B, Ols S, Perotti M, De van der Schueren W, Snijder J, et al. Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus. Cell. 2019;176:1420-1431.e17 pubmed publisher
  30. Bath N, Ding X, Wilson N, Verhoven B, Boldt B, Sukhwal A, et al. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model. PLoS ONE. 2019;14:e0211865 pubmed publisher
  31. Kobayashi T, Voisin B, Kim D, Kennedy E, Jo J, Shih H, et al. Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell. 2019;176:982-997.e16 pubmed publisher
  32. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed publisher
  33. Nguyen X, Dauvilliers Y, Quériault C, Pérals C, Romieu Mourez R, Paulet P, et al. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients. J Autoimmun. 2018;94:134-142 pubmed publisher
  34. Shi J, Hou S, Fang Q, Liu X, Liu X, Qi H. PD-1 Controls Follicular T Helper Cell Positioning and Function. Immunity. 2018;49:264-274.e4 pubmed publisher
  35. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  36. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  37. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  38. Georgiev H, Ravens I, Papadogianni G, Halle S, Malissen B, Loots G, et al. Shared and Unique Features Distinguishing Follicular T Helper and Regulatory Cells of Peripheral Lymph Node and Peyer's Patches. Front Immunol. 2018;9:714 pubmed publisher
  39. Cortes J, Ambesi Impiombato A, Couronné L, Quinn S, Kim C, da Silva Almeida A, et al. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. Cancer Cell. 2018;33:259-273.e7 pubmed publisher
  40. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  41. Shi B, Geng J, Wang Y, Wei H, Walters B, Li W, et al. Foxp1 Negatively Regulates T Follicular Helper Cell Differentiation and Germinal Center Responses by Controlling Cell Migration and CTLA-4. J Immunol. 2018;200:586-594 pubmed publisher
  42. Harly C, Cam M, Kaye J, Bhandoola A. Development and differentiation of early innate lymphoid progenitors. J Exp Med. 2018;215:249-262 pubmed publisher
  43. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  44. Liaskou E, Jeffery L, Chanouzas D, Soskic B, Seldin M, Harper L, et al. Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals. Sci Rep. 2017;7:7652 pubmed publisher
  45. Kim S, Kwon J, Park J, Seo H, Jung K, Moon Y, et al. Achaete-scute complex homologue 2 accelerates the development of Sjögren's syndrome-like disease in the NOD/ShiLtJ mouse. Immunol Lett. 2017;190:26-33 pubmed publisher
  46. Miyazaki M, Miyazaki K, Chen K, Jin Y, Turner J, Moore A, et al. The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development. Immunity. 2017;46:818-834.e4 pubmed publisher
  47. Minutti C, Jackson Jones L, Garcia Fojeda B, Knipper J, Sutherland T, Logan N, et al. Local amplifiers of IL-4R?-mediated macrophage activation promote repair in lung and liver. Science. 2017;356:1076-1080 pubmed publisher
  48. Chien C, Yu H, Chen S, Chiang B. Characterization of c-Maf+Foxp3- Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells. Sci Rep. 2017;7:46348 pubmed publisher
  49. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  50. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  51. Liu Z, Ravindranathan R, Kalinski P, Guo Z, Bartlett D. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun. 2017;8:14754 pubmed publisher
  52. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  53. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed publisher
  54. Chen S, Cai C, Li Z, Liu G, Wang Y, Blonska M, et al. Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. J Exp Med. 2017;214:475-489 pubmed publisher
  55. Kinosada H, Yasunaga J, Shimura K, Miyazato P, Onishi C, Iyoda T, et al. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors. PLoS Pathog. 2017;13:e1006120 pubmed publisher
  56. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  57. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  58. Ramirez Carrozzi V, Sambandam A, Zhou M, Yan D, Kang J, Wu X, et al. Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone. J Allergy Clin Immunol. 2017;139:705-708.e6 pubmed publisher
  59. Gerriets V, Kishton R, Johnson M, Cohen S, Siska P, Nichols A, et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 2016;17:1459-1466 pubmed publisher
  60. Johnston L, Hsu C, Krier Burris R, Chhiba K, Chien K, McKenzie A, et al. IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol. 2016;197:3445-3453 pubmed
  61. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  62. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  63. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  64. Drake L, Iijima K, Bartemes K, Kita H. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice. J Immunol. 2016;197:1335-42 pubmed publisher
  65. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  66. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  67. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  68. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  69. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  70. Kim J, Choi Y, Lee B, Song M, Ban C, Kim J, et al. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells. J Allergy Clin Immunol. 2016;137:1466-1476.e3 pubmed publisher
  71. Chandrasekaran U, Yi W, Gupta S, Weng C, Giannopoulou E, Chinenov Y, et al. Regulation of Effector Treg Cells in Murine Lupus. Arthritis Rheumatol. 2016;68:1454-66 pubmed publisher
  72. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  73. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed publisher
  74. Moretto M, Khan I. IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection. J Immunol. 2016;196:375-84 pubmed publisher
  75. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  76. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed publisher
  77. Choi Y, Gullicksrud J, Xing S, Zeng Z, Shan Q, Li F, et al. LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat Immunol. 2015;16:980-90 pubmed publisher
  78. Elsner R, Hastey C, Olsen K, Baumgarth N. Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection. PLoS Pathog. 2015;11:e1004976 pubmed publisher
  79. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  80. Lu K, Keppler S, Leithäuser F, Mattfeldt T, Castello A, Kostezka U, et al. Nck adaptor proteins modulate differentiation and effector function of T cells. J Leukoc Biol. 2015;98:301-11 pubmed publisher
  81. Liu B, Lee J, Chen C, Hershey G, Wang Y. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol. 2015;194:3583-93 pubmed publisher
  82. Pratama A, Srivastava M, Williams N, Papa I, Lee S, Dinh X, et al. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun. 2015;6:6436 pubmed publisher
  83. Stone E, Pepper M, Katayama C, Kerdiles Y, Lai C, Emslie E, et al. ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation. Immunity. 2015;42:239-251 pubmed publisher
  84. Clouthier D, Zhou A, Wortzman M, Luft O, Levy G, Watts T. GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection. PLoS Pathog. 2015;11:e1004517 pubmed publisher
  85. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed publisher
  86. Nelson M, Kundimi S, Bowers J, Rogers C, Huff L, Schwartz K, et al. The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol. 2015;194:1737-47 pubmed publisher
  87. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  88. Schwartz C, Turqueti Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A. 2014;111:E5169-77 pubmed publisher
  89. McKinstry K, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014;5:5377 pubmed publisher
  90. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed publisher
  91. Herati R, Reuter M, Dolfi D, Mansfield K, Aung H, Badwan O, et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol. 2014;193:3528-37 pubmed publisher
  92. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  93. Hong J, Amancha P, Rogers K, Courtney C, Havenar Daughton C, Crotty S, et al. Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol. 2014;193:797-806 pubmed publisher
  94. Gros A, Robbins P, Yao X, Li Y, Turcotte S, Tran E, et al. PD-1 identifies the patient-specific CD8? tumor-reactive repertoire infiltrating human tumors. J Clin Invest. 2014;124:2246-59 pubmed publisher
  95. Mathew R, Seiler M, Scanlon S, Mao A, Constantinides M, Bertozzi Villa C, et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature. 2012;491:618-21 pubmed publisher
  96. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  97. Onlamoon N, Hudson K, Bryan P, Mayne A, Bonyhadi M, Berenson R, et al. Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy. J Med Primatol. 2006;35:178-93 pubmed
  98. Smith P, Walsh C, Mangan N, Fallon R, Sayers J, McKenzie A, et al. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol. 2004;173:1240-8 pubmed